Getting to the root of problem
Pfizer is a therapy leader in Inflammation & Immunology. Many chronic inflammatory diseases are poorly managed by existing treatments that provide Suboptimal relief1. Our goal is to transform the treatment landscape by addressing the root cause of inflammation at the molecular level through advanced approaches that target inflammation of the joints and skin by disrupting pathways believed to play a role in inflammation2.
1. Bykerk V. Unmet needs in rheumatoid arthritis. J Rheumatol Suppl. 2009 Jun;82:42-6.
2. Demoruelle MK, Deane KD, Holers VM. When and where does inflammation begin in rheumatoid arthritis?. Curr Opin Rheumatol. 2014;26(1):64-71.
3. Ogdie A, de Vlam K, McInnes IB, et al Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. RMD Open 2020;6:e001042. doi: 10.1136/rmdopen-2019-001042
Vaccines
Oncology
Internal Medicine
Rare Diseases
Anti-infectives